Zydus Cadila receives tentative USFDA approval for Linagliptin Tablets EP News Bureau Oct 29, 2020 Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor to improve glycemic control in adults with Type 2 diabetes mellitus
